Article Text

Download PDFPDF
CASE REPORT
A rare case of Mycobacterium abscessus subspecies abscessus prosthetic valve endocarditis and the clinical importance of inducible erm(41) gene testing
  1. Norman Beatty1,
  2. Craig Brown1,
  3. Tirdad Zangeneh1,
  4. Mayar Al Mohajer2
  1. 1Department of Medicine, Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, Arizona, USA
  2. 2Department of Medicine, Baylor College of Medicine,Division of Infectious Diseases, Houston, Texas, USA
  1. Correspondence to Dr Norman Beatty, nbeatty{at}email.arizona.edu

Summary

A 56-year-old man with a history of injection drug use and two prior episodes of native valve infective endocarditis presented with dyspnoea on exertion. Our preliminary work-up revealed bacteraemia with reported growth of ‘Mycobacterium abscessus group’ on multiple blood cultures. The patient was later found to have eustachian valve and prosthetic pulmonic valve endocarditis. Initially, he responded to standard antimycobacterial therapy for rapidly growing mycobacteria (RGM) with supporting laboratory susceptibilities. However, he later developed refractory disease and persistent bacteraemia in the setting of these alleged susceptible antibiotics. Further molecular testing revealed a functional and inducible erm(41) gene which confers macrolide resistance. A subspecies analysis of the M abscessus group revealed the subspecies to be abscessus. We present a challenging case of M abscessus subsp. abscessus bacteraemia and prosthetic valve endocarditis with further discussion on treatment and management of this infection along with the taxonomic complexity of this ubiquitous RGM.

  • Infections
  • Drugs: infectious diseases
  • Medical management
  • Valvar diseases
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors NB and CB are responsible for the images acquired, patient consent for publication, history obtained and generation of original manuscript. MAM and TZ are responsible for reviewing original manuscript and any necessary revisions.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.